Analyst Ratings for Beam Therapeutics Inc (BEAM)
BEAM Rating Summary
BEAM Price Target Summary
- Highest: $78.00 (Guggenheim)
- Lowest: $30.00 (Jefferies)
- Average: $50.85
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$50.85 (+135.4%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
Avg. $ Target:
$50.85 (+135.4%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/29/2024 | JPMorgan » Updated 2/27/2024 |
Eric Joseph | Upgrade | Overweight (Neutral) |
44.00 (40.00) |
24.92 (21.60) |
-13.32% | Details |
| 12/15/2023 | BofA Securities | Greg Harrison | Downgrade | Neutral (Buy) |
35.00 (45.00) |
29.79 (21.60) |
-27.49% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
